Notably, post-TACE STIP1 level showed no correlation with baseline tumor size or AFP level, suggesting the universal use of post-TACE STIP1 level in evaluating response to single TACE treatment, regardless of baseline HCC status. Here, STIP1 is linked to hepatocellular carcinoma.